More than 40 years after the discovery of the spirochete responsible for Lyme disease, we are inching closer to understanding how Borrelia burgdorferi suppresses and evades the immune system.
https://t.co/eVrVD14xAd
Memphis-based US Biologic has partnered with New York-based company JP McHale to launch a product aimed at stopping the spread of Lyme Disease. US Biologic says the partnership will also help the company grow its local workforce. https://t.co/7SZahuMVoB
Looking for tips to pest-proof your home this summer? Watch the video below where our CEO and President Jim McHale talks on what to look out for, exclusively on @PIX11News: https://t.co/MXfvH5MrVY
JP McHale Pest Management continues to pave the way with innovative solutions. We recently partnered with US Biologic to integrate the LymeShield system into our fight against Lyme. To learn more, read the press release here: https://t.co/mAPeVdeqiC
#LymeDiseaseAwarenessMonth
We are excited to partner with the Connecticut Pest Control Association at the 2nd Annual Golf Outing and @PAPestAssoc at the Central Region Fall Seminar as we have been sharing our new transformative product, @lymeshield.
A new oral rodent vaccine has been approved by the @USDA to fight against the wildlife spread of lyme disease. Learn more about the development in @PMP_magazine below.
https://t.co/T5QcckCmJf
The US Department of Agriculture has conditionally licensed a Borrelia burgdorferi oral vaccine for mice. By removing a host for the bacteria that causes #LymeDisease, this vaccine can indirectly protect people and pets. https://t.co/volMKFDaFh
The US Department of Agriculture has conditionally licensed an oral Lyme vaccine that targets mice, so they will not pass the infection to ticks, which in turn cannot pass #LymeDisease to people and pets. The product is called LymeShield by @usbiologic
https://t.co/fHCl1DuKzm
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis pain and an oral vaccine against the wildlife spread of Borrelia burgdorferi, the bacterium responsible for Lyme disease, will soon hit the market. https://t.co/t3RZMr3XpS
The USDA just approved @usbiologic's wildlife vaccine to control the spread of Lyme disease. I wrote about their approach in @Nature in 2015: https://t.co/u9Rq43io63
US BIOLOGIC announced USDA Conditional Licensure of its novel oral vaccine against the wildlife spread of Borrelia burgdorferi, the bacterium responsible for Lyme disease, the number one vector-borne disease in the U.S. https://t.co/0a7Aawlqzr